Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases
Frank J. Dekker, Thea van den Bosch, Nathaniel I. Martin
Drug Discovery Today (2013) Vol. 19, Iss. 5, pp. 654-660
Open Access | Times Cited: 130

Showing 26-50 of 130 citing articles:

Small-molecule CBP/p300 histone acetyltransferase inhibition mobilizes leukocytes from the bone marrow via the endocrine stress response
Nikolai Jaschke, Dorit Breining, Maura Hofmann, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 364-378.e9
Open Access | Times Cited: 6
The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation
Shinji Toki, Kasia Goleniewska, Sara Reiss, et al.
Thorax (2016) Vol. 71, Iss. 7, pp. 633-645
Open Access | Times Cited: 60
Small Molecule Control of Chromatin Remodeling
Aidan Finley, Robert A. Copeland
Chemistry & Biology (2014) Vol. 21, Iss. 9, pp. 1196-1210
Open Access | Times Cited: 57
The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylases
Thea van den Bosch, Alexander P. Boichenko, Niek G.J. Leus, et al.
Biochemical Pharmacology (2015) Vol. 102, pp. 130-140
Open Access | Times Cited: 57
The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors
Fangyuan Cao, Martijn R. H. Zwinderman, Frank J. Dekker
Molecules (2018) Vol. 23, Iss. 3, pp. 551-551
Open Access | Times Cited: 55
Selective class IIa HDAC inhibitors: myth or reality
Eros Di Giorgio, Enrico Gagliostro, Claudio Brancolini
Cellular and Molecular Life Sciences (2014) Vol. 72, Iss. 1, pp. 73-86
Closed Access | Times Cited: 52
Epigenetic regulation of cardiac fibrosis
Matthew S. Stratton, Timothy A. McKinsey
Journal of Molecular and Cellular Cardiology (2016) Vol. 92, pp. 206-213
Open Access | Times Cited: 52
Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat Arthritis
Rink‐Jan Lohman, Abishek Iyer, Thomas Fairlie, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 356, Iss. 2, pp. 387-396
Open Access | Times Cited: 50
Maternal exposure to perfluorooctanoic acid (PFOA) causes liver toxicity through PPAR-α pathway and lowered histone acetylation in female offspring mice
Danyang Li, Linchao Zhang, Yan Zhang, et al.
Environmental Science and Pollution Research (2019) Vol. 26, Iss. 18, pp. 18866-18875
Closed Access | Times Cited: 49
Chemical Inhibitors of Epigenetic Methyllysine Reader Proteins
Natalia Milosevich, Fraser Hof
Biochemistry (2015) Vol. 55, Iss. 11, pp. 1570-1583
Closed Access | Times Cited: 46
Manipulating macrophage polarization and function using classical HDAC inhibitors: Implications for autoimmunity and inflammation
Asadollah Mohammadi, A Amin Sharifi, Reza Pourpaknia, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 128, pp. 1-18
Closed Access | Times Cited: 45
Targeting HDAC Complexes in Asthma and COPD
Martijn R. H. Zwinderman, Sander de Weerd, Frank J. Dekker
Epigenomes (2019) Vol. 3, Iss. 3, pp. 19-19
Open Access | Times Cited: 42
Potential epigenetic therapeutics for atherosclerosis treatment
Ioana Nicorescu, Geesje M. Dallinga‐Thie, Menno P.J. de Winther, et al.
Atherosclerosis (2018) Vol. 281, pp. 189-197
Closed Access | Times Cited: 41
Histone deacetylase 6 regulates endothelial MyD88-dependent canonical TLR signaling, lung inflammation, and alveolar remodeling in the developing lung
Heather Menden, Sheng Xia, Sherry M. Mabry, et al.
AJP Lung Cellular and Molecular Physiology (2019) Vol. 317, Iss. 3, pp. L332-L346
Open Access | Times Cited: 38
Clostridium tyrobutyricum alleviates Staphylococcus aureus-induced endometritis in mice by inhibiting endometrial barrier disruption and inflammatory response
Xiaoyu Hu, Jian Guo, Mingyue Xu, et al.
Food & Function (2019) Vol. 10, Iss. 10, pp. 6699-6710
Closed Access | Times Cited: 36
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration
Giuseppe Felice Mangiatordi, Francesca Intranuovo, Pietro Delre, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14448-14469
Closed Access | Times Cited: 34
Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches
Swati Bhat, Praveen Rishi, Vijayta Dani Chadha
Virus Research (2022) Vol. 318, pp. 198853-198853
Open Access | Times Cited: 19
Bromodomain-containing protein 4 activates androgen receptor transcription and promotes ovarian fibrosis in PCOS
Daojuan Wang, Zhengquan Zhu, Yu Fu, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113090-113090
Open Access | Times Cited: 11
c-Ski is a novel repressor of NF-κB through interaction with p65 and HDAC1 in U937 cells
Yan Peng, Ren‐Ping Xiong, Bo Wang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Fungal KATs/KDACs: A New Highway to Better Antifungal Drugs?
Karl Kuchler, Sabrina Jenull, Raju Shivarathri, et al.
PLoS Pathogens (2016) Vol. 12, Iss. 11, pp. e1005938-e1005938
Open Access | Times Cited: 38
The new HDAC1 inhibitor LG325 ameliorates neuropathic pain in a mouse model
Maria Domenica Sanna, Luca Guandalini, Maria Novella Romanelli, et al.
Pharmacology Biochemistry and Behavior (2017) Vol. 160, pp. 70-75
Closed Access | Times Cited: 37
Insights from pharmacological similarity of epigenetic targets in epipolypharmacology
J. Jesús Naveja, José L. Medina‐Franco
Drug Discovery Today (2017) Vol. 23, Iss. 1, pp. 141-150
Closed Access | Times Cited: 36
Histone Modifications and Asthma. The Interface of the Epigenetic and Genetic Landscapes
Courtney Kidd, Philip J. Thompson, Lucy Barrett, et al.
American Journal of Respiratory Cell and Molecular Biology (2015) Vol. 54, Iss. 1, pp. 3-12
Closed Access | Times Cited: 34
Valproic Acid Prevents Renal Dysfunction and Inflammation in the Ischemia-Reperfusion Injury Model
Elerson Costalonga, Filipe Miranda Oliveira Silva, Irene L. Noronha
BioMed Research International (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 34
Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy
E. Klieser, Stefan Swierczynski, Christian Mayr, et al.
World Journal of Gastrointestinal Oncology (2015) Vol. 7, Iss. 12, pp. 473-473
Open Access | Times Cited: 34

Scroll to top